GFAP and Parkinson disease: In the current study, a neuroinflammatory response was observed in PD mice, as the glia population increased after being MPTP challenged, which was characterized by higher levels of CD11b, Iba-1 and GFAP, the hallmarks of activated microglia and astrocytes.